| Literature DB >> 24288577 |
Ming Yang1, Josiah Poon, Shaomo Wang, Lijing Jiao, Simon Poon, Lizhi Cui, Peiqi Chen, Daniel Man-Yuen Sze, Ling Xu.
Abstract
Research on core and effective formulae (CEF) does not only summarize traditional Chinese medicine (TCM) treatment experience, it also helps to reveal the underlying knowledge in the formulation of a TCM prescription. In this paper, CEF discovery from tumor clinical data is discussed. The concepts of confidence, support, and effectiveness of the CEF are defined. Genetic algorithm (GA) is applied to find the CEF from a lung cancer dataset with 595 records from 161 patients. The results had 9 CEF with positive fitness values with 15 distinct herbs. The CEF have all had relative high average confidence and support. A herb-herb network was constructed and it shows that all the herbs in CEF are core herbs. The dataset was divided into CEF group and non-CEF group. The effective proportions of former group are significantly greater than those of latter group. A Synergy index (SI) was defined to evaluate the interaction between two herbs. There were 4 pairs of herbs with high SI values to indicate the synergy between the herbs. All the results agreed with the TCM theory, which demonstrates the feasibility of our approach.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24288577 PMCID: PMC3830796 DOI: 10.1155/2013/971272
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.238
Figure 1An illustrative example for data format and SCV calculation.
Statistic information for number of herbs.
| Per record | Per patient | Average number per patient per record | |
|---|---|---|---|
| Minimum | 9 | 9 | 9 |
| Average | 23 | 29 | 22 |
| Maximum | 36 | 73 | 33 |
Top 50 frequently used herbs.
| Rank | Record based | Patient based | ||
|---|---|---|---|---|
| Herb | Frequency | Herb | Frequency | |
| 1 | Chinese sage herb | 395 | Chinese sage herb | 147 |
| 2 | Doederlein's spikemoss herb | 393 | Doederlein's spikemoss herb | 146 |
| 3 | Akebia fruit | 359 | Akebia fruit | 133 |
| 4 | Herba | 332 | Herba | 129 |
| 5 |
| 321 |
| 127 |
| 6 | Rice-grain sprout | 268 | Astragalus root | 116 |
| 7 | Malt | 268 |
| 107 |
| 8 |
| 266 | Chicken gizzard membrane | 107 |
| 9 | Astragalus root | 263 | Rice-grain sprout | 106 |
| 10 | Chicken's gizzard-membrane | 252 | Malt | 106 |
| 11 | Common selfheal spike | 239 | Common selfheal spike | 104 |
| 12 | Rhizoma batatatis | 235 | Rhizoma batatatis | 97 |
| 13 | Coix seed | 223 | Coix seed | 96 |
| 14 | Tangerine peel | 195 | Coastal glehnia root | 86 |
| 15 | Coastal glehnia root | 195 | Oysters | 85 |
| 16 | Oysters | 183 | Tangerine peel | 80 |
| 17 | Rhizoma amorphophalli | 172 | Pericarpium trichosanthis | 79 |
| 18 | Pericarpium trichosanthis | 162 | Asparagus cochinchinensis | 72 |
| 19 | Asparagus cochinchinensis | 158 | Rhizoma amorphophalli | 68 |
| 20 | Edible tulip | 139 | Edible tulip | 64 |
| 21 |
| 133 |
| 62 |
| 22 |
| 122 | Tatarian aster root and rhizome | 58 |
| 23 | Chinese date | 120 | Shorthorned epimedium herb | 58 |
| 24 |
| 119 | Pilose asiabell root | 58 |
| 25 | Pilose asiabell root | 119 |
| 57 |
| 26 | Tatarian aster root and rhizome | 112 |
| 55 |
| 27 | Chinese taxillus herb | 111 | Chinese taxillus herb | 53 |
| 28 | Shorthorned epimedium herb | 109 | Chinese date | 53 |
| 29 |
| 99 |
| 51 |
| 30 | Baikal skullcap root | 98 | Heartleaf | 48 |
| 31 | Suberect spatholobus stem | 97 | Suberect spatholobus stem | 46 |
| 32 | Heartleaf | 95 | Glossy privet fruit | 46 |
| 33 | Glossy privet fruit | 91 | Baikal skullcap root | 45 |
| 34 | Noble | 89 | Balloon flower root | 43 |
| 35 | Chekiang fritillary bulb | 82 | Chekiang fritillary bulb | 42 |
| 36 | Paris polyphylla smith | 79 |
| 40 |
| 37 | Almond | 78 | Paris polyphylla smith | 40 |
| 38 |
| 76 | Barbary wolfberry fruit | 40 |
| 39 | Balloon flower root | 75 | Almond | 40 |
| 40 | Barbary wolfberry fruit | 73 | Noble | 39 |
| 41 |
| 65 | Cherokee rose fruit | 35 |
| 42 | Cherokee rose fruit | 63 | Chinese dodder seed | 32 |
| 43 | Reed rhizome | 57 |
| 31 |
| 44 | Toad skin | 57 | Reed rhizome | 30 |
| 45 | Radix | 55 | Toad skin | 30 |
| 46 | Fingered citron fruit | 55 | Common macrocarpa fruit | 29 |
| 47 | Chinese dodder seed | 54 | Immature bitter orange | 28 |
| 48 | Common macrocarpa fruit | 53 | Radix | 25 |
| 49 | Dragon's bones | 51 | Radish seed | 24 |
| 50 | Immature bitter orange | 51 | Dragon's bones | 24 |
Figure 2Data format for combinatorial optimization problem of discovery of CEF.
Figure 3Flow chart of GA and explanations of the sequence of GA steps for the discovery of CEF.
Figure 4Parameter selection in GA.
Parameters for GA.
| Parameter | Value |
|---|---|
| Population size | 1000 |
| Initial herb selection probability ( |
|
| Crossover probability ( | 0.7 |
| Tournament selection size ( | 15 |
| Generation | 200 |
Figure 5Fitness value by GA with different N and S 1 combination.
Traditional indications and biological effects of herbs.
| Herb | Abbreviation | Traditional indications# | Effects of cancer treatment | Reference |
|---|---|---|---|---|
| Astragalus root | AR | To reinforce | Immune stimulating effect. Improving quality of life for patients with nonsmall cell lung cancer. | [ |
| Akebia fruit | AF | To regulate | Popularly used for primary liver cancer treatment in China. | [ |
| Atractylis ovata | AO | To invigorate the function of the spleen and replenish | Antiangiogenic activity. Inhibiting the growth of B16 cancer cells. | [ |
| Chinese date | CD | To tonify the spleen, replenish | Antiproliferative activity in human breast cancer cells. | [ |
| Chinese sage herb | CS | To remove toxic heat and blood stasis and relieve pain. | Antiangiogenic activity. | [ |
| Coix seed | CSE | To transform dampness and promote water metabolism, to strengthen the spleen, and to clear heat and eliminate pus. | Affecting cellular pathways in neoplasia: to inhibit NFkappaB and protein kinase C signaling. | [ |
| Doederlein's spikemoss herb | DS | To remove toxic heat and dampness and to promote blood circulation and remove blood stasis. | Antiproliferative activity in three types of human cancer cells in vitro. | [ |
| Herba | HO | To eliminate heat and toxic material, to promote blood circulation and remove blood stasis, and to clear dampness heat. | Antiproliferative activity in eight cancer cell lines. Strengthening the patient's resistance. | [ |
| Malt | MA | To invigorate the function of the spleen, to regulate the function of the stomach, and to promote the flow of milk. | Proliferative function of colonic epithelial cells. | [ |
|
| PC | To cause diuresis, to invigorate the spleen function, and to calm the mind. | Inhibiting the growth of nonsmall cell lung cancer cells. | [ |
|
| PL | To induce diuresis, relieve dysuria, remove heat, and arrest bleeding. | Its active components: isomangiferin has capability of inhibiting virus replication within cells, and fumaric acid has chemopreventive potential for tobacco-nitrosamine-induced lung tumors. | [ |
|
| PT | To remove damp and phlegm, to relieve nausea and vomiting, and to eliminate stuffiness in the chest and the epigastrium. | Antiproliferative activity in five cancer cell lines in vitro. | [ |
| Rhizoma batatatis | RB | To replenish the spleen and stomach, to promote fluid secretion, and to benefit the lung. | Inhibiting the cancer cell line of melanoma B16 and Lewis lung cancer in mice in vivo. | [ |
| Rice-grain sprout | RS | To promote digestion, invigorate the function of the spleen, and improve appetite. | Popularly used for strengthening function of the spleen and the stomach during cancer treatment in China. | [ |
| Tangerine peel | TP | To regulate the flow of | Antioxidative and anti-inflammatory functions. Antiproliferative activity in human gastric cancer cells. | [ |
#Information is queried from TCM-ID database (http://bidd.nus.edu.sg/group/TCMsite/).
CEF obtained by GA.
| No. | Number of herbs | Composition | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AR | AF | AO | CD | CS | CSE | DS | HO | MA | PC | PL | PT | RB | RS | TP | ||
| 1 | 10 | X | X | X | X | X | X | X | X | X | X | |||||
| 2 | 9 | X | X | X | X | X | X | X | X | X | ||||||
| 3 | 8 | X | X | X | X | X | X | X | X | |||||||
| 4 | 9 | X | X | X | X | X | X | X | X | X | ||||||
| 5 | 8 | X | X | X | X | X | X | X | X | |||||||
| 6 | 10 | X | X | X | X | X | X | X | X | X | X | |||||
| 7 | 9 | X | X | X | X | X | X | X | X | X | ||||||
| 8 | 11 | X | X | X | X | X | X | X | X | X | X | X | ||||
| 9 | 10 | X | X | X | X | X | X | X | X | X | X | |||||
| 6 | 8 | 9 | 1 | 5 | 2 | 7 | 4 | 4 | 7 | 1 | 9 | 9 | 4 | 8 | ||
Core herb identification.
| Herb | Degree | Degree rank | Record based | Patient based | ||
|---|---|---|---|---|---|---|
| Frequency | Frequency rank | Frequency | Frequency rank | |||
| DS | 225 | 1 | 393 | 2 | 146 | 2 |
| CS | 225 | 2 | 395 | 1 | 147 | 1 |
| AF | 223 | 3 | 359 | 3 | 133 | 3 |
| AO | 220 | 4 | 321 | 5 | 127 | 5 |
| HO | 219 | 5 | 332 | 4 | 129 | 4 |
| PC | 207 | 6 | 266 | 8 | 107 | 7 |
| AR | 198 | 9 | 263 | 9 | 116 | 6 |
| CSE | 197 | 10 | 223 | 13 | 96 | 13 |
| RB | 194 | 11 | 235 | 12 | 97 | 12 |
| RS | 191 | 12 | 268 | 6 | 106 | 9 |
| MA | 191 | 13 | 268 | 7 | 106 | 10 |
| TP | 184 | 16 | 195 | 14 | 80 | 16 |
| CD | 158 | 30 | 120 | 23 | 53 | 28 |
| PT | 152 | 34 | 99 | 29 | 51 | 29 |
| PL | 127 | 47 | 65 | 41 | 31 | 43 |
Confidence and support of CEF.
| No. | α |
|
|
|
| PBS |
|---|---|---|---|---|---|---|
| 1 | 0.549 | 0.396 | 0.248 | 0.084 | 0.021 | 0.040 |
| 2 | 0.707 | 0.499 | 0.239 | 0.041 | 0.041 | 0.067 |
| 3 | 0.598 | 0.375 | 0.198 | 0.043 | 0.043 | 0.073 |
| 4 | 0.653 | 0.356 | 0.191 | 0.050 | 0.050 | 0.073 |
| 5 | 0.675 | 0.489 | 0.294 | 0.084 | 0.084 | 0.120 |
| 6 | 0.616 | 0.461 | 0.265 | 0.122 | 0.036 | 0.060 |
| 7 | 0.670 | 0.406 | 0.196 | 0.041 | 0.041 | 0.067 |
| 8 | 0.678 | 0.501 | 0.310 | 0.167 | 0.041 | 0.067 |
| 9 | 0.637 | 0.511 | 0.332 | 0.181 | 0.041 | 0.067 |
Z-test for the difference of EP for CEF.
| No. | EP of non-CEF group | EP of CEF group |
|
|---|---|---|---|
| 1 | 0.210 | 0.778 | 0.000 |
| 2 | 0.206 | 0.588 | 0.002 |
| 3 | 0.204 | 0.611 | 0.000 |
| 4 | 0.206 | 0.524 | 0.004 |
| 5 | 0.203 | 0.429 | 0.009 |
| 6 | 0.210 | 0.533 | 0.013 |
| 7 | 0.206 | 0.588 | 0.002 |
| 8 | 0.206 | 0.588 | 0.002 |
| 9 | 0.206 | 0.588 | 0.002 |
Leave one (patient) out analysis to test the robustness of effectiveness (total 150 times).
| No. | EP of non-CEF group | EP of CEF group | −log ( | |||
|---|---|---|---|---|---|---|
| Mean | Range | Mean | Range | Mean | Range | |
| 1 | 0.209 | [0.204, 0.213] | 0.778 | [0.750, 0.857] | 4.215 | [3.308, 5.867] |
| 2 | 0.206 | [0.201, 0.210] | 0.589 | [0.563, 0.643] | 2.764 | [2.314, 3.194] |
| 3 | 0.204 | [0.199, 0.208] | 0.612 | [0.588, 0.667] | 3.273 | [2.791, 3.779] |
| 4 | 0.206 | [0.201, 0.209] | 0.524 | [0.500, 0.579] | 2.360 | [1.990, 2.936] |
| 5 | 0.203 | [0.197, 0.206] | 0.429 | [0.412, 0.455] | 2.036 | [1.757, 2.337] |
| 6 | 0.210 | [0.205, 0.214] | 0.533 | [0.500, 0.583] | 1.859 | [1.335, 2.160] |
| 7 | 0.206 | [0.201, 0.210] | 0.589 | [0.563, 0.643] | 2.764 | [2.314, 3.194] |
| 8 | 0.206 | [0.201, 0.210] | 0.589 | [0.563, 0.643] | 2.764 | [2.314, 3.194] |
| 9 | 0.206 | [0.201, 0.210] | 0.589 | [0.563, 0.643] | 2.764 | [2.314, 3.194] |
Core-ness and effectiveness evaluation of 15 core herbs combination.
| α |
| EP of non-CEF group | EP of CEF group |
|
|---|---|---|---|---|
| 0.605 | 0.009 | 0.217 | 0.750 | 0.014 |
Figure 6Distribution of SI.
Analysis of herb-herb interactions in CEF.
| No. | Herb pair | SI |
| |
|---|---|---|---|---|
| 1 | PL | PT | 1.673 | 0.004 |
| 2 | CD | PT | 1.419 | 0.012 |
| 3 | CSE | PL | 1.363 | 0.028 |
| 4 | PT | TP | 1.077 | 0.025 |